Evaluation of heteroscorpionate ligands as scaffolds for the generation of Ruthenium(II) metallodrugs in breast cancer therapy

Keywords

Heteroscorpionate ligands

TNBC

RAPTA derivatives

Preclinical evaluation

Uptake studies

Fluorescence lifetime imaging microscopy

Data availability

No data was used for the research described in the article.

© 2024 The Authors. Published by Elsevier Inc.

View original article

JOURNAL OF INORGANIC BIOCHEMISTRY

0 0 0 0 0 0 0

留言 (0)